EE226 Cost-Effectiveness Analysis of Fixed-Dose Triple Combination Therapy (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) Vs. Its Fixed-Dose Double Combination and Individual Components
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.527
https://www.valueinhealthjournal.com/article/S1098-3015(23)00627-7/fulltext
Title :
EE226 Cost-Effectiveness Analysis of Fixed-Dose Triple Combination Therapy (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) Vs. Its Fixed-Dose Double Combination and Individual Components
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00627-7&doi=10.1016/j.jval.2023.03.527
First page :
Section Title :
Open access? :
No
Section Order :
10015